<DOC>
	<DOCNO>NCT02628288</DOCNO>
	<brief_summary>Comparison heal response treatment complex bifurcation lesion dedicate bifurcation device ( Axxess™ Biolimus Eluting Coronary Bifurcation Stent System + Absorb BVS distal branch ) versus Modified T stenting technique use Absorb BVS : optical coherence tomography ( OCT ) analysis .</brief_summary>
	<brief_title>COmplex Bifurcation PCI : AXXESS Device + Absorb BVS , v Modified T Stenting With Absorb BVS</brief_title>
	<detailed_description>This prospective single center randomize clinical trial baseline OCT clinical , angiographic OCT follow-up thirty month . Patients true complex coronary bifurcation lesion randomly assign treatment dedicate Axxess biolimus-eluting bifurcation stent proximal main vessel ( MV ) additional Absorb everolimus-eluting BVS branch versus modify T technique use Absorb BVS . The primary endpoint change minimal luminal area assess OCT baseline 30 month pre-specified bifurcation segment . The main aim ass acute performance compare long-term vessel heal optical coherence tomography , clinical angiographic outcome treatment complex bifurcation lesion dedicate stent additional Absorb Bioabsorbable scaffold ( BVS ) versus modify T stenting technique Absorb BVS .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Patient old 18 year 2 . The subject stable unstable angina pectoris , positive functional study ischemia . 3 . The subject eligible PCI , acceptable candidate coronary artery bypass surgery . 4 . The subject male , female , childbearing potential negative urine serum pregnancy test within 7 day index procedure intention become pregnant within year procedure . 5 . The subject sign informed consent prior procedure , agree comply follow requirement . 6 . Patients de novo true coronary bifurcation lesion ( Medina classification ( 1,1,1 ) , ( 1,0,1 ) ( 0,1,1 ) ) anatomical presentation require double stent technique judgment operator . 7 . Coronary artery proximal parent vessel reference diameter 2.75 3.75 mm branch vessel diameter ≥ 2.25 mm ( visual estimate ) . 8 . The lesion must least 50 % diameter stenosis within either MB SB ( visual estimate ) . 9 . Regarding lesion length : lesion able cover 2 Absorb BVS Modified Tstenting technique , combination maximally 1 AXXESS 2 Absorb BVS ( visual estimate ) . 10 . The side branch ostium locate least 10 mm leave main coronary artery ( visual estimate ) . 11 . The angle sidebranch parent vessel le 70° ( visual estimate ) . 1 . Left ventricular ejection fraction &lt; 30 % 2 . Impaired renal function ( serum creatinine &gt; 2.0 mg/dl ) 3 . Previous and/or plan brachytherapy target vessel 4 . Known allergy antiplatelet , anticoagulation therapy , contrast medium , biolimus everolimus , nickel , titanium polyD , Llactic Acid . 5 . Pregnant and/or breastfeed female female intend become pregnant ( pregnancy test require ) 6 . Patients life expectancy less three year 7 . Patient currently enrol investigational device drug trial primary endpoint timing reach potentially interfere outcome either trial 8 . Patient able willing adhere followup visit 9 . Patients intend major surgical intervention within 12 month enrolment study . 10 . Patients previously participate study . 11 . Subject experience acute myocardial infarction 72 hour prior index procedure , define either presence new Qwave 2 contiguous lead , CK great two time site upper reference limit ( URL ) presence creatine KinaseMB ( CKMB ) great site URL . 12 . Creatinine Kinase ( CK ) great two time URL presence CKMB great site URL time procedure . 13 . The subject suffer stroke transient ischemic neurological attack cerebrovascular accident within past six month , know intracranial mass , arteriovenous malformation , aneurysm intracranial pathology 14 . The subject experience significant gastrointestinal genitourinary bleed within past six month , active bleeding within two month . 15 . The subject take warfarin NOAC , need take warfarin novel oral anticoagulant ( NOAC ) post procedure , international normalise ratio ( INR ) &gt; 1.4 . 16 . Planned revascularization within 1 year index procedure . 17 . The target vessel contain intraluminal thrombus . 18 . The target lesion locate leave main coronary artery 19 . Lesion leave main trunk &gt; 50 % , unprotected 20 . The subject another lesion within target vessel parent side branch require treatment besides bifurcation lesion 21 . The subject prior PCI target lesion , include 5mm zone proximal distal lesion 22 . The target lesion show angiographic evidence severe calcification tortuosity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>